BELEMSI
DEAD

Serial Number

79232230

Owner

NOVARTIS AG

Filing Date

Mar 19, 2018

Add to watchlist:

No watchlists yet
View on USPTO

BELEMSI Trademark

Serial Number: 79232230 • Registration: 5583109

BELEMSI is a trademark filed by NOVARTIS AG on March 19, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 19, 2018

Registration Date

October 16, 2018

Published for Opposition

July 31, 2018

Cancellation Date

January 20, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 20, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 8, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 8, 2025 OPNR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Dec 6, 2023 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 11, 2023 CRCV
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Feb 20, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Feb 20, 2022 DETH
NOTIFICATION PROCESSED BY IB
Dec 20, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 4, 2018 FICS
FINAL DISPOSITION PROCESSED
Dec 4, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 15, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 16, 2018 R.PR
PUBLISHED FOR OPPOSITION
Jul 31, 2018 PUBO
NOTICE OF PUBLICATION
Jul 11, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 23, 2018 CNSA
ASSIGNED TO EXAMINER
Jun 8, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
May 26, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 22, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 18, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 17, 2018 REPR